04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
In an article published in the September 2019 issue of DRI's For The Defense magazine, Ricardo Woods...
Read More >
We recently reported on a new law in the Netherlands that sets different unemployment insurance cont...
Read More >
The Federal Trade Commission and the Antitrust Division of the U.S. Department of Justice released t...
Read More >
Oil & gas dealmaking has plummeted following a period of prolonged low oil prices and a steep fall i...
Read More >
For the one-year period beginning September 1, 2019 and ending August 31, 2020, plan sponsors of sta...
Read More >
Another day, another new Google antitrust lawsuit—this time thanks to a group of 30-plus states tha...
Read More >